Morgan Labbree, Author at Precision Medicine Group

Executive Summary: State of the Industry

Morgan Labbree2023-07-24T21:06:57-04:00Cell & Gene Therapy, News, Thought Leadership|

Tim Hunt, CEO of the Alliance for Regenerative Medicine (ARM), kicked off the event with a briefing on the state of the cell and gene therapy development landscape. With 475 members worldwide, ARM focuses on convening the sector, providing data and analysis, engaging with stakeholders, and enabling the development of advanced therapies. One of their key initiatives is modernizing healthcare systems to enable access to these novel therapeutics. Highlights of this briefing are provided in this summary.

(more…)

Article: Innovations in Gene Therapies

Morgan Labbree2023-07-12T12:12:27-04:00Cell & Gene Therapy|

Despite innovation to date in gene therapy, safety concerns with adeno-associated virus (AAV) vectors and uneasiness around cost and affordability has brought into focus the need for even more advancement in the field. In this Pharma Live article, Precision’s Phil Cyr discusses some of the innovations that are occurring to address these issues.

(more…)

Webinar: Maximizing Efficiency in Your Next State of the Art Facility Build

Morgan Labbree2023-06-20T11:58:00-04:00Cell & Gene Therapy, Events|

Sponsored by Project Farma, a Precision for Medicine Company, this panel will feature insights from industry leaders on their organization’s risk-based approaches, strategies, and regulatory, manufacturing, and commercial needs to maximize efficiency in their facility build.

This discussion will be moderated by Chad Salisbury: SVP (Project Farma), and include insights from Adam Barlow: CEO and Founder (Baseline Controls), Antinea Chair: VP, Technical Operations (Cellares), Steve Marr: Head of Capital, Real Estate, and Facilities (Spark), Matthew Smith: Head of Project Delivery (Novartis), and Sarah Stoll: Sr. Director (Project Farma).

(more…)

White Paper: Gene Editing Breakthroughs: A New Hope for Patients

Morgan Labbree2023-06-20T14:19:37-04:00Cell & Gene Therapy, News, Thought Leadership|

Gene editing technology has rapidly evolved over the past decade. From the initial breakthrough of sequencing the first human genome to researchers today having the ability to create genetically modified mice in as little as four weeks. CRISPR Cas-based gene editing, which acts as a pair of genomic scissors, is at the core of these innovations. The revolutionary technology has enabled rapid genome sequencing and editing to spur advancements in disease research and treatment.

In this white paper, Anshul Mangal President of Project Farma and Precision ADVANCE and Cynthia Pussinen, Advisor & Executive Consulting Partner share how the latest breakthroughs in gene editing technology have the potential to dramatically improve outcomes for patients.

(more…)

White Paper: Moving CGTx Clinical Development Forward in 2023

Morgan Labbree2023-06-20T14:21:24-04:00Cell & Gene Therapy, Thought Leadership|

Clinical trials are foundational to developing innovative, life-saving treatments and cures for patients. For developers of cell and gene therapy (CGTx) products, the path to clinical success is fraught with vast and complex challenges. The CGTx field is becoming more crowded, with increased clinical trial volume and an influx of less-experienced sponsors contributing to an increase in clinical holds in the category. Such challenges intensify the pressure to succeed in a fiercely competitive environment.

(more…)

White Paper: Market Trends and Expectations for Advanced Therapies in 2023

Morgan Labbree2023-07-06T11:12:25-04:00Cell & Gene Therapy, Thought Leadership|

The cell and gene therapy space has undergone transformational change in the last few years, driven by the promise these modalities have demonstrated in addressing rare and intractable diseases. Achievements in the CAR-T therapy space – there are now six approved CAR-T treatments on the market – in conjunction with breakthroughs in gene therapy and viral vector drugs, have signaled a new era of innovation aimed at furthering cell and gene therapies within the greater healthcare landscape.

(more…)

Conference: 3rd Gene and Cell Therapies: CMC, CGT & Vector Manufacturing Summit

Morgan Labbree2023-06-15T15:58:07-04:00Cell & Gene Therapy, Events, Thought Leadership|

Precision will be at this year’s 3rd Gene and Cell Therapies: CMC, CGT & Vector Manufacturing Summit, June 20-21, 2023, in Vienna, Austria. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the development for cell and gene therapies.

Connect with our Advanced Therapy experts!

Schedule a meeting with one our our experts
Be sure to attend Precision’s own, Houria Bachtarzi’s presentation on June 20, 2023, at 10:10 AM CEST

You can register for the 3rd Gene and Cell Therapies: CMC, CGT & Vector Manufacturing Summit below:

REGISTER HERE

(more…)

Event: Cell & Gene Reception @ BIO, 2023

Morgan Labbree2023-05-23T13:40:58-04:00Cell & Gene Therapy, Events, Thought Leadership|

Precision is honored to be a co-host of this year’s ARM Cell & Gene Reception @ BIO, May 5, 2023, in Boston, MA. Attendees will enjoy extensive networking opportunities with the sector’s top decision makers including executives from leading companies located in the Boston area!

Connect with our Advanced Therapy experts!

Date: Monday, June 5, 2023
Time: 6:00pm – 9:00pm ET
Location: Woods Hill Pier 4, Boston, MA

Registration is complimentary – CLICK HERE to reserve your spot.

(more…)

Conference: ASGCT, 2023

Morgan Labbree2023-05-17T10:37:09-04:00Cell & Gene Therapy, Events, Thought Leadership|

Precision will be at this year’s ASGCT, May 16-20, 2023, in Los Angeles, CA. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the development for cell and gene therapies.

Connect with our Advanced Therapy experts!

Visit us at booth 754 in the exhibition area
Be sure to attend Precision’s own, Travis Harrison’s presentation on May 19, 2023, at 4:45PM PDT – 5:15PM PDT

You can register for ASGCT below:

REGISTER HERE

(more…)